Economics of Using Biocidal Surfaces - Use of Biocidal Surfaces for Reduction of Healthcare Acquired Infections - page 179

Table 8.7 Outcome
(before - after)

Outcome Before After

Improvement 20 11

Death 16 21

Totals 36 32

Fig. 8.8 Decline to hospitalization days

Fig. 8.9 Days of hospitalization

The pharmaceutical costs in general and specifically the antimicrobial drug
costs, is known to be (perhaps) the main economic parameter to the function of
ICU and generally of a hospital in every health system. The variation depends on
parameters such as the severity of the patient, the management of the medical and
nursing staff, but also from HAI (microbial flora ICU), and the development of
antibiotic-resistant pathogenic strains. The overuse of antimicrobials in recent years
has created major problems, both to health systems and to patients' treatment from
the development of resistant pathogenic strains, even to the latest antimicrobials.